BALT Group
PrivateLast Round
Debt
Dec 20, 2024
Total Funding Raised
$367.1M
Company Overview
BALT Group is a therapeutic devices company that manufactures interventional neuroradiology devices to treat strokes, aneurysms, and other neurovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BALT Group Comps
Public and private peers based on sector, stage, and business model.
BALT Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 20, 2024 | ||||
| Grant | May 19, 2021 | ||||
| Buyout/LBO | Sep 25, 2015 |
BALT Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 20, 2024
$365M debt round completed.
- May 19, 2021
Secured $2.1M in grant funding.
BALT Group Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BALT Group's valuation, stock price, and market status.
